Altria Stock Pops on FDA's Latest Juul Update

The stock is coming off its worst month on record

Digital Content Manager
Jul 6, 2022 at 10:09 AM
facebook X logo linkedin

Altria Group Inc (NYSE:MO) is up 1.6% at $42.37, after the U.S. Food and Drug Administration (FDA) said it was temporarily lifting its ban on Juul e-cigarette products as it conducts an additional review of Juul's marketing application. Altria owns a 35% stake in the company, and has been feeling the heat as the FDA looks to take Juul products off the shelves in the U.S. for good. The agency added, however, that the "stay and the agency's review does not constitute authorization to market, sell, of ship JUUL products."

Last month was a miserable one for Altria stock, which lost 22.8% in June, marking its biggest monthly drop on record. The equity looks to have found a floor at the $41 level, which marks an annual low for MO, while the 10-day moving average has been keeping a lid on any additional upside gains. 

Despite the recent plummet, short sellers have been hitting the exits. Short interest dropped 14.7% in the last reporting period, and now makes up just a slim 1% of the stock's available float. 

Options bears, on the other hand, have been targeting MO at an elevated clip. This is per the security's Schaeffer's 10-day volume ratio of 0.99 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which sits higher than all but 2% of readings from the past year. 


Unlock Weekend Profits with Chris Prybal's Favorite Strategy Up +487.5% in 2024

With the markets going left, right, and sideways, you need to have a plan now more than ever. 

Expert Trader Chris Prybal is no stranger to volatility, and has mastered finding big stock rallies while other traders aren't looking over the weekend. Rallies that produced gains like +207% on RTX calls, +236% on MARA calls, and +238% on NET calls.

A few simple moves on Sunday at 7pm could be the “Secret Sauce” your portfolio needs to not just stay afloat, but make unprecedented gains in this turbulent market.

Don’t sit on the sidelines, beat the market with Chris Prybal's strategy. Join him now!